A Study to Assess the Effect of Hepatic Impairment on Safinamide Pharmacokinetics

Clinical trial NCT01027169 · COMPLETED

Trial details

NCT number: NCT01027169
Sponsor: Newron Pharmaceuticals SPA
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2009-04-01
Primary completion: 2009-10-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.